These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6868097)

  • 1. Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration.
    Kok PW; Kenya PR; Ensering H
    Trans R Soc Trop Med Hyg; 1983; 77(2):171-6. PubMed ID: 6868097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 3. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 4. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
    Norrby E; Enders-Ruckle G; Meulen V
    J Infect Dis; 1975 Sep; 132(3):262-9. PubMed ID: 1159329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles immunization: new recommendation.
    Krugman S
    JAMA; 1977 Jan; 237(4):366. PubMed ID: 576171
    [No Abstract]   [Full Text] [Related]  

  • 8. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of children with attenuated measles-rubella bivalent vaccine.
    Ramos-Alvarez M; Miller BH; Jackson JE; Schwarz AJ; Bessudo L
    Am J Dis Child; 1975 Apr; 129(4):474-7. PubMed ID: 1093389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures.
    Lancet; 1977 Sep; 2(8038):571-5. PubMed ID: 71396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles in Tanzania: antibody response in children after vaccination and antibody state of mothers and newborns.
    de Haas PW; Masurel N; Anker WJ
    Trans R Soc Trop Med Hyg; 1983; 77(2):267-70. PubMed ID: 6868109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
    Simon JK; Pasetti MF; Viret JF; Mischler R; Muñoz A; Lagos R; Levine MM; Campbell JD
    Hum Vaccin; 2007; 3(2):54-8. PubMed ID: 17312403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
    Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.